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SUMMARY
Humans with Wiskott-Aldrich syndrome display a
progressive immunological disorder associated
with compromised Wiskott-Aldrich Syndrome Inter-
acting Protein (WIP) function. Mice deficient in WIP
recapitulate such an immunodeficiency that has
been attributed to T cell dysfunction; however, any
contribution of B cells is as yet undefined. Here we
have shown that WIP deficiency resulted in defects
in B cell homing, chemotaxis, survival, and differenti-
ation, ultimately leading to diminished germinal cen-
ter formation and antibody production. Furthermore,
in the absence of WIP, several receptors, namely the
BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR4,
were impaired in promoting CD19 co-receptor acti-
vation and subsequent PI3 kinase (PI3K) signaling.
The underlying mechanism was due to a distortion
in the actin and tetraspanin networks that lead to
altered CD19 cell surface dynamics. In conclusion,
our findings suggest that, by regulating the cortical
actin cytoskeleton, WIP influences the function of
CD19 as a general hub for PI3K signaling.
INTRODUCTION
Naive B cells express a B cell receptor (BCR) composed of
the nonsignaling membrane immunoglobulins (Ig) IgM and
IgD, which recognize extracellular antigen, and the associated
signaling transmembrane components Ig-a and Ig-b, containing
immunoreceptor tyrosine-based activation motifs (ITAMs) (Reth,
1989; Weiss and Littman, 1994). Cognate antigen recognition by
the BCR initiates rapid phosphorylation of the ITAMs, which form
a signaling platform for the tyrosine kinases Lyn and Syk. Subse-
quently both kinases recruit and phosphorylate several adaptor
proteins and the co-receptor CD19. CD19 further recruits other
molecules such as the Vav adaptor protein, Bruton’s tyrosine ki-
nase (Btk), the PI3 kinase (PI3K) subunit p85a and Lyn itself via its
cytosolic domain thus lowering the threshold of B cell activation
(Carter and Fearon, 1992). In addition, CD19 plays a prominent
role in PI3K pathway activation after BCR ligation (Otero et al.,
2001).
To initiate the signaling cascade, early antigen recognition re-
quires alteration of the actin cytoskeleton, enabling the spreading
and contraction of B cells across the surface of antigen-present-
ing cells (Fleire et al., 2006). Antigen-inducedBCRsignaling leads
toanearly rapidwaveof actin depolymerization that is dependent
on the amount of BCR cross-linking (Hao and August, 2005). This
radical reorganization of the actin cytoskeleton removes barriers
to BCR diffusion and modifies BCR dynamics at the cell surface.
In addition, TLRsignaling hasbeenshown to influenceactin orga-
nization, thereby increasing BCR mobility and facilitating BCR
signaling (Freeman et al., 2015). Furthermore, changes in actin
organization alone increasesBCRdiffusion and triggers signaling
similar to BCR crosslinking (Treanor et al., 2010). This ligand-in-
dependent signal not only requires increased BCR diffusion but
also an immobilized co-receptor CD19, held in place by its asso-
ciation with the tetraspanin molecule CD81 (Mattila et al., 2013).
In this context, we believe CD19 provides amechanism for signal
amplification via the PI3K pathway; however, the molecular link-
agebetweenCD19, thePI3Kpathway, and theactin cytoskeleton
is incompletely defined.
The PI3K pathway is one of the main signaling pathways regu-
lating B cell homeostasis, survival, differentiation, and class-
switch recombination. In addition to the BCR, several other
receptors have been shown to activate the PI3K pathway in B
cells, including chemokine and cytokine receptors, Toll-like re-
ceptors and receptors of the tumor necrosis factor (TNF) family,
namely BAFFR and CD40 (Arron et al., 2001; Patke et al., 2006).
Recently, it has been suggested that CD19 also mediates PI3K
signaling in response to BAFFR or CD40 stimulation (Hojer
et al., 2014; Jellusova et al., 2013) and raises the question of a
general involvement of CD19 in PI3K activation in B cells.
WIP, theWiskott-Aldrich syndrome protein (WASP) interacting
protein, which is encoded by the Wipf1 gene, plays a key regu-
latory role in remodeling of the actin cytoskeleton. WIP binding
to WASP, a central activator of the Arp2/3 complex, protects it
from degradation and regulates its cellular distribution (Fried
et al., 2014). WIP promotes actin polymerization independently
of WASP by binding and stabilizing actin filaments (Martinez-
Quiles et al., 2001; Ramesh et al., 1997). Furthermore, WIP
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associates with the adaptor molecules Nck and Grb2, thus
potentially linking the actin network to signaling cascades (Anto´n
et al., 1998; Barda-Saad et al., 2005; Donnelly et al., 2013; Mor-
eau et al., 2000).
In humans,mutations in theWIP binding site ofWASP (Stewart
et al., 1999) or inWIP itself (Lanzi et al., 2012) results in the devel-
opment of the immunodeficiency Wiskott-Aldrich syndrome
(WAS). WAS is an X-linked disorder associated with eczema,
increased susceptibility to infections and heightened risk of
autoimmune disorders (Thrasher, 2009). Mice deficient in WIP
display severe lymphopenia, increased spleen size but reduced
numbers of B cells, lack of marginal zone B cells and a severe
T cell dysfunction thus mimicking WAS (Curcio et al., 2007).
WIP-deficient B cells exhibit defects in their actin network and
increased proliferation in response to BCR stimulation in vitro
(Anto´n et al., 2002); however, the role of WIP in B cell activation
remains to be studied.
Here, we have shown that WIP deficiency in B cells resulted
in defects in homing, chemotaxis, survival, and differentiation,
ultimately leading to a reduction in germinal centers and anti-
body production in response to infection or immunization.
These defects were the result of an impaired CD19 activation
and PI3K signaling in WIP-deficient B cells after triggering a va-
riety of receptors, namely BCR, BAFFR, CXCR4, CXCR5, CD40,
and TLR4. Addressing the underlying mechanism, we found a
distorted actin cytoskeleton and CD81-tetraspanin network in
WIP-deficient B cells, which resulted in altered cell surface
mobility of CD19. On the basis of these findings, it appears
that WIP, by controlling actin-dependent receptor dynamics, in-
fluences CD19 in its function as a general hub for PI3K signaling.
RESULTS
B Cell-Specific WIP Deficiency Impairs Mouse Immune
Responses to Viral Infection or Immunization
To establish whether the absence of WIP exclusively in B cells
has any effect in altering humoral immune responses, we gener-
ated mixed bone marrow (BM) chimeras by adoptively trans-
ferring a mix of WIP-deficient BM (from now on Wipf1/ cells
referring to its standard gene symbol) and BM from mice that
lack B cells (JHT mice) into lethally irradiated JHT recipients. In
this setting, all newly generated B cells will be Wipf1/ in an
environment containing mainly WT cells.
Wipf1/ and wild-type (WT) chimeric mice were challenged
with a low dose (1 3 104 PFU) of Vaccinia virus intra footpad.
Eight days later, using flow cytometry, the generation of germinal
center (GC) B cells was measured as a percentage of
GL7+CD95+ of B220+ B cells. We observed a robust formation
of GC B cells in the draining lymph node of WT chimeras, with
16% of B cells staining positive for GCmarkers. This percentage
was significantly diminished to 9%when B cells were deficient in
WIP (Figure 1A). We also observed a marked diminution in the
percentage of T follicular helper cells (CD4+CXCR5+PD1+) from
13% to 7% in Wipf1/ chimeras (Figure 1A), suggesting a
defective interaction between Wipf1/ B cells and T cells.
Similar to our observations after Vaccinia virus infection, B cell
responses were severely impaired whenWipf1/ chimeric mice
were challenged with the T cell-dependent antigen NP-KLH.
Here, the GC B cell population was reduced from 14.1% to
4.1% in Wipf1/ chimeras (Figure 1B). Furthermore, using
confocal microscopy, we detected smaller Bcl-6+ GC in frozen
sections of spleens from immunized Wipf1/ chimeras, with
substantially reduced numbers of Wipf1/ GC cells compared
to WT GC cells (an average of 22 Wipf1/ cells compared to
an average of 970 WT cells) (Figure 1C). Quantifying NP-specific
antibody titers in the serum, we found that Wipf1/ chimeras
had about one-fifth of the NP-specific IgM antibody concentra-
tion compared to WT chimeras. Notably, the production of NP-
specific IgG antibody titers was severely delayed and reduced
with IgG1 and IgG3 antibodies titers being diminished by at least
one-fourth inWipf1/ chimericmice (Figure 1D). The substantial
reduction in the percentage of GC B cells and the differences in
antibody production were unlikely to be due to a reduction of the
percentage of circulating B cells in Wipf1/ chimeras to about
half that of the WT chimeras (Figures S1A and S1B), but mainly
indicate an intrinsic differentiation defect in the absence of
WIP. Furthermore, we observed a similarly impaired GC B cell
response ofWipf1/ cells when we challenged chimeras recon-
stituted with a mixture of 50% CD45.2 Wipf1/ BM and 50%
CD45.1 WT BM with NP-KLH in alum (Figure S1C).
Collectively, these in vivo experiments suggest that B cell-
specific WIP deficiency renders mice unable to respond effec-
tively to viral infection or immunization.
Wipf1–/– B Cells Show Impaired Homing and Migration
During analysis of the mixed chimeras, we found the expected
ratio of approx. 50:50 (50% CD45.1+ WT cells versus 50%
CD45.2+ Wipf1/ cells) in the B cell compartment of the BM
and the blood (Figures 2A and 2B). However, we observed a ratio
of approx. 70:30 of CD45.1+WTB cells versusCD45.2+Wipf1/
B cells in the spleen and lymph node (Figure 2B). A similar differ-
ence in the percentages of cells homing to spleen and lymph
nodes was observed when fluorescently labeled CD45.1+ WT
and CD45.2+ Wipf1/ B cells were adoptively transferred into
WT recipients (Figure S2A). Together, these results indicate
that Wipf1/ B cells might be deficient in their capacity to
migrate and/or to sense chemokines.
We next investigated the steady-state migration of naive
B cells in vivo. For this, fluorescently labeled WT and Wipf1/
B cells were adoptively transferred into WT recipients. After
24 hr, both cell types were found in similar regions of explanted
popliteal and inguinal lymph nodes using two-photon micro-
scopy, indicating that both cell types are able to localize to
B cell follicles (Figure 2C). While WT B cells moved with an
average speed of 6.2 ± 0.07 mm/min, Wipf1/ B cells were
significantly slower with an average speed of 5.1 ± 0.1 mm/min
(Figure 2C; Movie S1). In addition, Wipf1/ B cells showed
30% less displacement during the acquisition period compared
to WT B cells. These results support our hypothesis that WIP
might regulate cell migration in vivo.
Homing of B cells to follicles in secondary lymphoid organs
involves migration mediated by the chemokines CXCL12 and
CXCL13 (Okada et al., 2002). We found WIP to be slightly phos-
phorylated after stimulating naive B cells with CXCL12 as
measured by flow cytometry (Figure S2B), likely indicating an
involvement of WIP in chemokine signaling. We next evalu-
ated the B cell chemotactic response to a gradient of these
chemokines in vitro using transwell plates. Here,Wipf1/Bcells
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displayed a significant reduction in the percentage of migratory
B cells to both, CXCL12 and CXCL13 compared toWT cells (Fig-
ure 2D). This reduction was not due to altered expression of
CXCR4 (the receptor binding CXCL12) and CXCR5 (the receptor
binding CXCL13) on the B cell surface (Figure S2C). Examining
signaling after CXCR4 stimulation, Wipf1/ B cells displayed a
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Figure 1. B Cell-Specific WIP Deficiency Compromises Humoral Immune Responses
JHT-WT or JHT-Wipf1/mixed BM chimeric mice were infected intra footpad with Vaccinia virus (A) or immunized intra-peritoneally with NP-KLH in alum (B–D).
(A) Analysis of immune responses in popliteal lymph nodes at day 8 post-infection by flow cytometry. GC cells (B220+CD95+GL7+) or Tfh cells (CD4+CD44+
CD62LPD-1+CXCR5+) are shown. Quantifications (right column) indicate the percentage of GC B cells or Tfh cells per lymph node analyzed (mean ± SEM).
(B and C) Analysis of splenic NP-specific GC cells (NP+B220+CD95+GL7+) at day 13 post-immunization by flow cytometry. Immunohistochemistry showing IgD+
B cell follicles, Bcl-6 expressing GC cells and TCR-b+ T cell areas in frozen spleen sections. Graph indicates quantifications of GC cells in spleen sections (mean ±
SEM). Scale bar, 150 mm.
(D) ELISA of NP-specific IgM, IgG, IgG1, and IgG3 antibodies in the sera of immunized chimeras at indicated time points (mean ± SEM).
Data are representative of two independent experiments (eight mice each).
See also Figure S1.
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severely diminished phosphorylation of Akt kinase, used as an
indicator for PI3K signaling, when compared to WT B cells
(Figures 2E and 2F). A similar reduced phosphorylation of Akt
was observed in Wipf1/ WEHI-231 B cells. Re-expression of
WIP in Wipf1/ WEHI B cells restored Akt phosphorylation to
amounts similar to those in WTWEHI cells (Figure S2E). Further-
more, splenicWipf1/B cells showed a 50% reduction in phos-
phorylation of the transcription factor Foxo and a 80% reduction
in phosphorylation of p70S6K compared to the phosphorylation
in WT cells, both downstream targets of the PI3K signaling
pathway (Figures 2E and 2F; Figure S2D).Wipf1/ B cells stim-
ulated with CXCL13 similarly displayed severely diminished acti-
vation of the PI3K/Akt signaling pathway when compared to WT
cells (Figures 2E and 2F; Figure S2D).
Together, these results demonstrate an impaired chemokine
receptor-induced PI3K signaling in Wipf1/ B cells. In line
with this, we also found reduced chemokine-sensing and migra-
tion of these cells in vitro and in vivo, which likely contributes to a
decreased humoral immune response in Wipf1/ mice.
BCR Signaling Requires WIP for PI3K Pathway
Activation
To address whether WIP was recruited to active sites of BCR
signaling, we expressed human GFP-WIP in WEHI-231 B cells.
These cells were settled on planar lipid bilayers containing Alexa
Fluor 633-labeled antibody against the BCR (anti-BCR) to mimic
the interaction of B cells with antigen-presenting cells (Fleire
et al., 2006). Immediately after B cells contacted the membrane,
GFP-WIPwas recruited to sites of antigen aggregation (Figure 3A
and Movie S2). In parallel, we found strong phosphorylation
of WIP at residue S488 already 3 min after BCR cross-linking
of naive WT B cells, as detected by flow cytometry (Figure 3B)
or immunoblot (Figure S3A). These findings demonstrate that
during early events of BCR signaling, WIP is recruited to signal-
osomes. This recruitment is concomitant with an increase in
phosphorylation of the protein.
We next investigated whether ablation of WIP influences the
quantity of filamentous actin (F-actin) in activated B cells. We
found that Wipf1/ B cells exhibited a lower amount of F-actin
when B cells were allowed to spread on coverslips coated with
immobilized antigen. Such difference was mainly manifested
by the absence of visible F-actin foci measured by total internal
reflection microscopy (TIRFM) (with an average of 6.8 F-actin
foci per WT cell compared to an average of 0.8 F-actin foci in
Wipf1/ cells), but resulted neither in the incapacity to spread
nor in a defect of F-actin polymerization at the leading edge
(Figure 3C).
We next tested the capacity of Wipf1/ cells to internalize
antigen. B cells were loaded with fluorescent microspheres
containing anti-k-chain antibody on ice, washed to remove un-
bound microspheres, and then incubated at 37C to allow BCR
internalization. Wipf1/ B cells internalized less particulate
antigen compared to WT B cells at all time-points analyzed
(Figure S3B), indicating that WIP-mediated reorganization of
the actin cytoskeleton might be necessary for BCR-mediated
antigen internalization.
We went on to measure BCR-induced Ca2+ mobilization in
naive splenic B cells by flow cytometry and found it to be
increased in Wipf1/ B cells relative to that of WT B cells (Fig-
ure S3D). This was not due to increased BCR expression on the
surface of Wipf1/ B cells (Figure S3C). Next, we stimulated
bothcell typeswitha solubleanti-k-chainantibodyandmeasured
theBCR-inducedphosphorylation of Syk andErk kinases, aswell
as the PI3K subunit p85, Akt and Foxo. Both WT andWipf1/ B
cells displayed robust phosphorylation of Syk and Erk after BCR
cross-linking. Of note, naive Wipf1/ B cells expressed higher
basal phosphorylation of Syk and Erk (Figures 3D and 3E). How-
ever,Wipf1/Bcells showed an at least 50% reduction of phos-
phorylation of p85, Akt and Foxo compared to WT cells (Figures
3D and 3E). Similar results for Erk and Akt phosphorylation after
stimulation were obtained using flow cytometry (Figure S3E).
We next investigated whether WIP deficiency influences B cell
survival. In addition to BCR signaling, the BAFFR pathway is
critical for survival of B cells. We detected slightly lower expres-
sion of BAFFR on the surface of Wipf1/ B cells compared to
WT cells by flow cytometry (Figure S3F). Cultivating purified
splenic B cells fromWipf1/ or WTmice in either unconditioned
medium or in the presence of BAFF, we found reduced survival in
the absence of WIP. In cultures with BAFF, only 40% ofWipf1/
B cells were alive at day 3 compared to 60% of WT B cells (Fig-
ure 3F). In line with the impaired survival, phosphorylation of Akt
was impaired inWipf1/Bcells after short-term stimulation with
BAFF (Figure 3G). These results suggest a role of WIP in BAFFR-
induced PI3K activation and survival.
Collectively, these results demonstrate that, in the absence of
WIP, the actin cytoskeleton after BCR stimulation is altered.
Figure 2. WIP Deficiency Affects B Cell Homing and Chemotaxis
(A) Flow cytometric analysis of BM mixture (B220+CD45.1+ WT and B220+CD45.2+ Wipf1/ BM in a mixture of 1:1) before transfer into irradiated recipients.
(B) Flow cytometric analysis of WT cells (B220+CD45.1+) and Wipf1/ cells (B220+CD45.2+) in indicated organs of mixed BM chimeras (upper row). Graphs
(±SEM) indicate the percentage of B220+CD45.1+ WT and B220+CD45.2+ Wipf1/ cells in respective organs. Data are representative of three independent
experiments (nR 4 mice).
(C) Representative two-photon microscopy images 24 hr after adoptive transfer of labeled WT (cyan) and Wipf1/ (red) B cells. Left image is a whole fixed
popliteal lymph node (scale bar, 150 mm). B cell follicles are highlighted in gray for illustrative purposes. Middle and right images are examples of the visualization
(including representative tracks) of homeostatic movement (scale bars, 30 mm). Smaller images indicate two representative cells, highlighted by arrows at
different times. Graphs (±SEM) on the bottom right indicate the quantification of the average speed over the span of themovie and themean displacement length.
Data are representative of three independent experiments.
(D) Chemotactic response of purified WT and Wipf1/ B cells to CXCL12 (left graph) or CXCL13 (right graph) using transwell plates. Graphs (±SEM) show
percentages of migrating cells normalized to the starting input number of B cells set to 100%. Data are pooled from four independent experiments.
(E) Immunoblot of splenic WT or Wipf1/ B cells treated with CXCL12 or CXCL13 and probed with antibodies as indicated.
(F) Quantifications of intensity of proteins normalized by densitometry to total Erk or tubulin and to the signal in unstimulated WT cells at t = 0. Data are
representative of at least three independent experiments.
See also Figure S2and Movie S1.
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Figure 3. WIP Is Required for Efficient BCR-
Induced Activation of the PI3K Pathway
(A) TIRF microscopy of WEHI-231 B cells ex-
pressing GFP-WIP imaged after spreading over a
planar lipid bilayer labeled with anti-k-chain anti-
body linked to Alexa Fluor 633 (left) and quantifi-
cation of fluorescent intensities along the white
diagonal line (right, colors match labels above
images). Scale bar, 3 mm.
(B) Flow cytometric analysis of WIP phosphor-
ylation after anti-k-chain stimulation of WT
B cells. Grey shaded histogram represents the
unstimulated WT control. Graph shows the mean
fluorescent intensity (MFI) normalized to theMFI of
Wipf1/ cells at indicated time points.
(C) Phalloidin staining indicating intracellular
amount of F-actin in fixed WT or Wipf1/ B cells
settled on coverslips coated with anti-k-chain
antibody for 10 min. Scale bar, 3 mm. Quantifica-
tion (right graph) shows F-actin foci per cell
(mean ± SEM). Data are representative of three
independent experiments.
(D and E) Immunoblot of splenic WT or Wipf1/
B cells stimulated with anti-k-chain antibody and
probed with antibodies as indicated. Quantifica-
tions of intensity of proteins normalized by densi-
tometry to total Erk or tubulin and to the signal in
unstimulated WT cells at t = 0. Data are repre-
sentative of at least three independent experi-
ments.
(F) Graph show mean (±SEM) percentage of live
WT or Wipf1/ B cells cultured in medium or in
the presence of BAFF at different time points,
normalized to the starting input number of live B
cells set to 100%. Results pooled from three in-
dependent experiments with one mouse each.
(G) Immunoblot of splenic WT or Wipf1/ B cells
stimulated with BAFF, probed with antibodies
against p-Akt and Erk. Quantifications of intensity
of proteins normalized by densitometry to total Erk
and to the signal in unstimulated WT cells at t = 0.
(D and G) Experiments were performed simulta-
neously with experiments in Figure 5A and there-
fore results can be directly compared. The loading
control measurements (Erk for anti-k-chain and
BAFF stimulation) were part of both experiments.
See also Figure S3and Movie S2.
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Furthermore, WIP deficiency led to impaired PI3K signaling after
BCR cross-linking, which eventually results in a reduced BAFFR-
triggered survival.
Formation of Plasma Cells In Vitro Depends on WIP
Mediated PI3K Signaling
We went on to measure phosphorylation of WIP in response to
CD40 and Toll-like receptor-4 (TLR4) stimulation by flow cytom-
etry and immunoblot, respectively, and found WIP to be phos-
phorylated, again indicating a direct contribution of WIP in
response to those stimuli (Figures S4A and S4B). We next
analyzed the activation status of Akt and Foxo after triggering
CD40 and TLR4 in WT and Wipf1/ B cells by immunoblot.
We observed robust phosphorylation of Akt and Foxo in WT
B cells, but phosphorylation of both was strongly reduced
in Wipf1/ B cells (Figures 4A and 4B), similar to our results
A B
C D
Figure 4. WIP Regulates PI3K Signaling and Mediates Class-Switching and Plasma Cell Formation In Vitro
(A and B) Immunoblot of splenic WT orWipf1/ B cells stimulated with CD40L (A) or LPS (B), probed with antibodies as indicated. Quantifications of intensity of
proteins normalized by densitometry to Erk or tubulin, and to the signal in unstimulated WT cells at t = 0. This experiment and experiment in Figure S4D were
performed simultaneously. The loading control measurements were part of both experiments.
(C and D) CTV labeled splenic WT andWipf1/ B cells were stimulated for 4 days with CD40L (C) or LPS (D) and IL-4 and IL-5. Flow cytometry measurements of
proliferation (CTVdilution, upper row), class-switch recombination (IgG1+ cells,middle row) andplasma cell differentiation (CD138hi cells, lower row). Graphs on the
right of (C) and (D) indicate the percentages of class-switched and PCs normalized to total live cells. Data are pooled from at least three experiments (mean ± SEM).
See also Figure S4.
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after BCR and chemokine receptor stimulation. Furthermore, we
measured reduced phosphorylation of Akt after CD40 stim-
ulation of Wipf1/ WEHI-231 B cells by flow cytometry, which
was restored to the amount of phosphorylation in WT cells after
re-expression of WIP (Figure S4F). Thus, WIP deficiency might
indeed lead to a general impaired PI3K and Akt activation.
We next analyzed whether the defect in PI3K/Akt signaling
was reflected in the capability ofWipf1/B cells to class-switch
and differentiate into plasma cells (PCs). Splenic WT and
Wipf1/ B cells were cultivated with either CD40L or LPS in
the presence or absence of interleukin-4 (IL-4) and IL-5 in vitro.
After four days of culture, both,Wipf1/ andWT B cells prolifer-
ated extensively to CD40L stimulation as indicated by the dilu-
tion of CTV (Figure 4C). However, in response to LPS or LPS in
the presence of IL-4 and IL-5,Wipf1/B cells showed amarked
increase in the percentage of proliferating cells of 80% versus
50% when compared to WT B cells (Figure 4D). This correlated
with an increase in Erk phosphorylation as detected by immuno-
blot (Figures S4D and S4E). Furthermore, Wipf1/ B cells
showed a 2–3 times higher percentage of class-switched cells
compared to WT cells in both stimulatory conditions (Figures
4C and 4D). The proportion of Wipf1/ PCs (evaluated by
CD138 expression) was substantially diminished to less than
half (Figures 4C and 4D). Taken together, these results indicate
that WIP is required for PI3K pathway activation and thus regu-
lates class-switch recombination and plasma cell formation.
WIP Regulates PI3K Activation via Phosphorylation
of CD19
Having identified an essential function forWIP in regulating PI3K/
Akt signaling in response to stimulation of chemokine receptors,
BAFFR, cross-linking of the BCR or the co-receptor CD40 or
TLR4, we wondered whether the co-receptor CD19 itself might
be involved in all the signaling pathways we analyzed. As ex-
pected, triggering of the BCR, BAFFR, and CD40 induced robust
phosphorylation of CD19 (Figures 5A and 5B). Triggering of
TLR4, CXCR4, and CXCR5 also induced low but consistent
phosphorylation of CD19 (Figures 5A and 5B). Furthermore, we
noted that, in B cells lacking WIP, basal CD19 phosphorylation
was reduced, likely contributing to overall reduced CD19 phos-
phorylation after stimulation. We found that triggering CD40,
TLR4, and CXCR4 induced phosphorylation of Src family ki-
nases and that this phosphorylation was again reduced in the
absence of WIP (Figure S5A). Together, these results indicate
that CD19 is not only a critical component of the BCR, BAFFR,
and CD40 pathway but might also be relevant for PI3K signaling
after TLR4, CXCR4, and CXCR5 stimulation. In addition, WIP is
involved in these signaling pathways possibly influencing the
phosphorylation of CD19.
Cd19/micehavebeen repeatedlyused tostudy the roleof the
PI3K/Aktpathway inBcell function (Depoil et al., 2008;Engel et al.,
1995; Fujimoto et al., 1999; Rickert et al., 1995). We used B cells
fromCd19/mice to compare results of experiments performed
under similar conditions. Of note, BCR cross-linking of Cd19/
Bcells induceda robust phosphorylationofWIP (FigureS5E), sug-
gesting that WIP activation might be independent of CD19
signaling. Wewent on to investigate the effect of CD19 deficiency
on plasma cell formation in vitro. Splenic purified B cells from
Cd19/ and WT mice were cultivated with either LPS or CD40L
in the presence or absence of IL-4 and IL-5 as described before.
After 4 days in culture, both, Cd19/ and WT B cells proliferated
extensively (Figure 5C and Figure S5C). In similarity to what has
been observed in cultures of Wipf1/ B cells, the proportion of
Cd19/ B cells that underwent class-switch recombination was
about 2-fold higher compared to WT cells when stimulated with
CD40L (Figure 5D). However, class-switch recombination of
Cd19/ B cells in response to LPS was comparable to WT cells
(Figure S5B). Furthermore,Cd19/ B cells demonstrated a com-
plete block in differentiation into CD138-positive PCs (Figure 5D).
In line with these results, and similar to results obtained with
Wipf1/ B cells, Cd19/ B cells showed reduced Akt and
Foxo phosphorylation after CD40L or LPS stimulation (Figures
5E and 5F and Figure S5D).
Again similar to results withWipf1/B cells, we found that the
chemotaxis of Cd19/ B cells toward a gradient of CXCL13
using transwell plates was significantly reduced compared to
WT B cells (Figure 5G). In addition, Cd19/ B cells displayed
diminished phosphorylation of Akt and Foxo in response to
CXCL13 stimulation compared toWT cells (Figure 5H). These ex-
periments demonstrate that Cd19/ B cells recapitulate many
of the phenotypes observed inWipf1/B cells, providing strong
evidence that WIP is involved in regulating the PI3K pathway via
CD19 activation.
WIP Regulates BCR and CD19 Diffusion on the B Cell
Surface
How could WIP affect CD19 activation? We noticed that
while CD19 expression was similar on the surface of WT and
Figure 5. WIP Regulates PI3K Activation via Phosphorylation of CD19
(A) Immunoblot of splenicWT orWipf1/B cells stimulated with (from top to bottom) anti-k-chain antibody, BAFF, CC40L, LPS, CXCL12, or CXCL13 and probed
with antibodies as indicated. Experiments were performed simultaneously with experiments in Figure 3 (anti-k-chain and BAFF), Figure 4 (LPS) and Figure S2D
(CXCL12 and CXCL13). Single loading control measurements are shown in figures.
(B) Quantifications of intensity of proteins stimulated as in (A) normalized by densitometry to Erk or tubulin and to the signal in unstimulated WT cells at t = 0.
(C–F) CTV labeled splenic WT and Cd19/ B cells were stimulated for 4 days with CD40L and IL-4 and IL-5. Flow cytometry measurements of (C) proliferation
(CTV dilution), (D) class-switch recombination (IgG1+ cells, upper row) and plasma cell differentiation (CD138hi cells, lower row). Graphs on the right of (D) indicate
the percentages of class-switched and PCs normalized to total live cells. Data are pooled from at least three experiments (mean ± SEM).
(E and F) Immunoblot of splenic WT or Cd19/ B cells stimulated with CD40L and probed with antibodies as indicated. Quantifications of intensity of proteins
normalized by densitometry to actin and to the signal in unstimulated WT cells at t = 0.
(G) Chemotactic response of purifiedWT and Cd19/ B cells to CXCL13 using transwell plates. Graphs (±SEM) show percentages of migrating cells normalized
to the starting input number of B cells set to 100%. Data are pooled from three independent experiments.
(H) Immunoblot of splenic WT or Cd19/ B cells stimulated with CXCL13 and probed with antibodies as indicated. Quantifications of intensity of proteins
normalized by densitometry to Erk and to the signal in unstimulated WT cells at t = 0.
See also Figure S5.
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Wipf1/Bcells, expression of the tetraspanin protein CD81was
reduced on Wipf1/ B cells (Figure 6A). No substantial alter-
ations in the expression of other members of the tetraspanin
family were detected in the absence of WIP (data not shown).
A reduction in CD81 was also observed in two independent
Wipf1/ cell lines generated by employing the CRISPR/Cas9
deletion system. Transient re-expression of WIP in Wipf1/
A20 cells increased CD81 expression (Figures S6A–S6D) further
supporting the notion that WIP is required to maintain CD81
expression.
In resting B cells, CD81 stabilizes and immobilizes CD19 on
the cell surface (Mattila et al., 2013). To investigate whether
WIP deficiency alters CD19 dynamics, we performed single-par-
ticle tracking of CD19 by incubating primary B cells with limited
amounts of fluorescently labeled anti-CD19 Fab fragments
followed by analysis with TIRFM. While CD19 was relatively
immobile on the surface of resting WT cells, CD19 particles on
the surface ofWipf1/ B cells showed an accelerated diffusion,
with themedian diffusion coefficient increasing from 0.008 mm2/s
on WT B cells to 0.03 mm2/s onWipf1/ B cells (Figures 6B and
6C and Movie S3). A more detailed analysis revealed two
different populations of CD19 in WT cells, with a slower diffusion
population centered around D = 0.003 mm2/s and a population
retaining higher mobility (centered around D = 0.032 mm2/s).
CD19 diffusion of both, the slower and higher populations accel-
erated on Wipf1/ B cells with the slower diffusion population
centered around D = 0.010 mm2/s and the higher diffusion pop-
ulation centered around D = 0.060 mm2/s) (Figure 6D). These
results indicate that the reduced CD81 amount indeed correlate
with an increase in CD19 dynamics, likely leading to a misplace-
ment of the co-receptor.
We went on to analyze the impact of WIP deficiency on BCR
dynamics on resting B cells. While CD19 is immobilized by the
tetraspanin network, BCR mobility is regulated by the cortical
actin cytoskeleton. Measuring phalloidin staining by flow cytom-
etry, we observed a reduced amount of F-actin in naiveWipf1/
B cells when compared to WT B cells (Figure 6E). Given this
reduction in F-actin in steady state and the impaired actin poly-
merization after BCR stimulation, we wondered whether the
diffusion of the BCR was altered in the absence of WIP. As pre-
viously shown (Mattila et al., 2013), we observed a very low
mobility of a large proportion of IgD particles in resting WT
B cells, with a median diffusion coefficient of 0.008 mm2/s.
Notably, onWipf1/ B cells, we detected a 2-times accelerated
diffusion of IgD particles, with a median diffusion coefficient of
0.015 mm2/s (Figure 6F, right graph). Although IgM is already
quite mobile on resting WT B cells, we detected a slight but
consistent increase also in IgM diffusion onWipf1/B cells (Fig-
ure 6F, left graph). The diffusion of CD40was also accelerated on
Wipf1/ B cells (Figure S6F). From these results, we conclude
that the diminished amount of F-actin in Wipf1/ B cells is re-
flected in higher mobility of B cell receptors.
In view of the impaired CD19 phosphorylation and the altered
dynamics of CD19, we next analyzed whether Wipf1/ B cells
were able to react to the disruption of the actin cytoskeleton
through the actin monomer-sequestering agent Latrunculin A
(LatA). Compared to WT cells, Wipf1/ B cells displayed a
markedly delayed calcium response to LatA treatment together
with a severely impaired capability to phosphorylate the co-re-
ceptor CD19 and the signaling molecules Akt, Syk, and Erk
(Figures 6G and 6H). These results show that in the absence of
WIP, ligand-independent signaling via CD19 triggered by actin
cytoskeleton disruption is distorted, again hinting at the regula-
tory effect of WIP in mediating CD19 activation. We thus suggest
that in the absence of WIP, the actin cytoskeleton but also the
CD81 tetraspanin network is disturbed, leading to an increased
diffusion of both, the BCR and CD19 on resting cells. This
possibly causes an altered organization of B cell surface recep-
tors, leading to a misplacement of the receptors and impaired
signaling.
DISCUSSION
Here, we have shown that WIP functions as a regulator of CD19
activation and PI3K/Akt signaling in B cells. WIP deficiency re-
sulted in defects in homing, chemotaxis, survival and differenti-
ation, highlighting an essential role for WIP in B cell function.
Furthermore, in the absence ofWIP, B cells displayed distortions
in the actin cytoskeleton and the CD81-tetraspanin network,
which resulted in altered cell surface mobility of the BCR and
CD19. These changes in surface receptor dynamics resulted in
reduced phosphorylation of CD19 after triggering a variety of
receptors and thus place CD19 at the heart of PI3K signaling in
B cells.
Challenging mixed BM chimeras with either Vaccinia virus
or NP-KLH revealed that WIP deficiency compromised GC for-
mation and antibody production, thereby hampering humoral
immune responses. Similarly, the small Rho GTPase Cdc42, a
known regulator of actin remodeling and interaction partner of
WASP and N-WASP, controls GC formation and antibody
production in B cells (Burbage et al., 2015). In contrast, B cells
deficient for WASP mount a normal antibody response to
T-dependent immunization (Recher et al., 2012; Snapper et al.,
1998). This can be partly explained by compensatory effects of
the ubiquitously expressed protein N-WASP (Westerberg et al.,
2012). We therefore suggest that the impaired capability of our
mixed BM chimeras to mount a humoral immune response is
due to the absence of WIP in B cells.
We have further shown that WIP regulated chemotaxis of
B cells toward the chemokines CXCL12 and CXCL13, mediating
B cell homing to lymph nodes and spleen. In support of our find-
ings, WIP functions in F-actin-rich lamellopodium formation and
amoeboid motility in response to CXCL13 in vitro (Banon-Rodri-
guez et al., 2013). T cells lacking the actin-binding domain ofWIP
displayed decreased cellular F-actin content, impaired chemo-
taxis and defective homing to lymph nodes although having
normal WASP expression (Gallego et al. 2006; Massaad et al.,
2014). These findings strongly argue for a crucial role for WIP
in regulating actin-cytoskeleton-mediated migration.
Early signaling events following BCR stimulation by mem-
brane-bound antigen trigger the formation of antigen microclus-
ters (Fleire et al., 2006). We found here that WIP was recruited to
microclusters and phosphorylated at the serine residue S488
immediately after BCR engagement, suggesting that WIP partic-
ipates in the early events after antigen recognition. How phos-
phorylation regulates WIP function in B cells is unclear to date.
In T cells, S488 of WIP is phosphorylated in a PKCQ-dependent
manner in response to T cell receptor (TCR) activation, mediating
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Figure 6. WIP Regulates BCR and CD19 Diffusion on
the B Cell Surface
(A) Flow cytometric analysis of CD19 and CD81 on the surface
of WT (blue line) or Wipf1/ (red line) B cells. Grey shaded
histogram indicates the isotype control. Graph (mean ± SEM)
on the right shows the MFI of CD81 expression on splenic
B cells of 4 WT and 4 Wipf1/ mice.
(B) Single-particle tracking (SPT) of CD19 on WT or Wipf1/
B cells settled on nonstimulatory coverslips. Shown is the
diffusion coefficient (D) in mm2/s. The median of 300 repre-
sentative cells is given as value and indicated by black bars.
1,000–2,000 tracks were analyzed with a minimum of 20 cells
from 3 experiments.
(C) Trajectories of CD19 in WT (left) and Wipf1/ cells (right)
showing diffusion of single particles over 10 s and magnified
regions from white rectangles. Scale bar, 2 mm.
(D) Analysis of the CD19 diffusion coefficient plotted in a
logarithmic histogram and fitted to two distinct populations
exhibiting slower (light gray) and faster (dark gray) diffusion on
WT (left graph), Wipf1/ (middle graph) and a comparison of
the CD19 diffusion on WT and Wipf1/ B cells (right graph).
(E) Flow cytometric analysis of F-actin by intracellular phal-
loidin staining of resting WT (blue line) or Wipf1/ (red line)
B cells.
(F) SPT of IgM and IgD on WT or Wipf1/ B cells settled on
nonstimulatory coverslips. Shown is the diffusion coefficient
(D) in mm2/s. 1,000–2,000 trackswere analyzed with aminimum
of 20 cells from 2 experiments. The median of 300 represen-
tative cells is given as value and indicated by black bars.
(G) Ratiometric intracellular Ca2+ flux of WT and Wipf1/
B cells, stimulated with Latranculin A and analyzed by flow
cytometry. Results are presented as fluorescent emission at
450 nm relative to that at 530 nm. Data are representative of
three independent experiments.
(H) Immunoblot of splenic WT or Wipf1/ B cells stimulated
with Latrunculin A and probed with antibodies as indicated.
Quantifications of intensity of proteins normalized by densi-
tometry to Erk or tubulin and to the signal in unstimulated WT
cells at t = 0.
See also Figure S6 and Movie S3.
670 Immunity 43, 660–673, October 20, 2015 ª2015 The Authors
the recruitment of WASP to the immunological synapse (Fried
et al., 2014; Sasahara et al., 2002). In contrast, tyrosine phos-
phorylation of WIP by Btk triggers the release of WASP from
the WIP–WASP complex, resulting in WASP degradation and
termination of actin filament generation (Vijayakumar et al.,
2015). Phosphorylation and activation of WIP in B cells might
thus regulate actin dynamics. Indeed, in the absence of WIP,
we found lower amounts of F-actin in resting B cells and less
F-actin foci when B cells spread on antigen-coated coverslips.
Similar F-actin foci were recently described as being a WASP-
generated fraction of the total synaptic F-actin in T cells (Kumari
et al., 2015). We suggest that, in B cells, WIP plays a central
role in cytoskeletal actin dynamics that is triggered by the
engagement of a variety of receptors, having shown that BCR
crosslinking, CXCL12, CD40, and TLR4 signaling all induce the
phosphorylation of WIP.
A high percentage of WAS patients develop autoimmune
diseases. Similarly, B cell-intrinsic deletion of WASP is sufficient
to induce autoantibody production and antibody deposition in
the kidneys of mice (Becker-Herman et al., 2011; Recher et al.,
2012). In the absence of the WASP homolog N-WASP, B cells
show delayed BCR internalization, enhanced tyrosine phosphor-
ylation and higher Ca2+ flux (Liu et al., 2013). WIP interacts with
N-WASP but is not required for its stability (de la Fuente et al.,
2007). InWipf1/ B cells, N-WASP activation upon BCR stimu-
lation was only mildly impaired (data not shown), suggesting that
the negative regulatory role of WIP is probably independent of
N-WASP function. We found that Wipf1/ B cells displayed an
increased Ca2+ flux after BCR crosslinking, enhanced prolifera-
tion, a delayed and reduced BCR internalization, and increased
basal phosphorylation of Syk and Erk. These findings are in
line with a previous report suggesting that blocking of BCR
endocytosis leads to hyperphosphorylation of Syk and Erk and
lower phosphorylation of the PI3K pathway (Chaturvedi et al.,
2011). We suggest that the higher basal Syk activation in
Wipf1/ B cells might explain the partially hyperreactive pheno-
type, because Syk is both essential to and sufficient for antigen-
induced Ca2+ flux after BCR clustering by multimeric ligands
(Mukherjee et al., 2013; Takata et al., 1994).
In B cells, CD19 contributes to BAFF- and CD40-mediated
survival, consistent with CD19 phosphorylation and Akt activa-
tion (Hojer et al., 2014; Jellusova et al., 2013). Here, we extend
this model by showing that triggering a variety of receptors,
namely the BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR, led
to the phosphorylation of CD19. We thus suggest a critical role
for CD19 as a general ‘‘hub’’ of PI3K signaling. The precise mo-
lecular mechanism by which CD19 is phosphorylated remains
unclear. Recent data demonstrated that BAFFR stimulation
triggers the phosphorylation of the Iga chain and Syk, poten-
tially leading to CD19 activation (Schweighoffer et al., 2013).
Furthermore, in a model of CD40 overexpression, CD19 phos-
phorylation is likely mediated by the Src family kinase Lyn (Hojer
et al., 2014). We indeed detected Lyn phosphorylation after
triggering of most of the receptors studied. We moreover have
demonstrated here that CD19 phosphorylation is dependent
on WIP. Wipf1/ B cells were unable to efficiently phosphory-
late CD19. Concomitantly, activation of the PI3K/Akt pathway
was impaired, leading to multiple defects in homing, survival,
class-switching, and antibody production. Supporting our hy-
pothesis, many of the defects seen inWipf1/Bcells were reca-
pitulated in B cells lacking CD19.
Dissecting the molecular mechanism of how WIP might
mediate the function of CD19, we found that in the absence of
WIP, BCR and CD19 diffusion is enhanced. We recently showed
that in the plasmamembrane of resting B cells, the BCR is immo-
bilized by the actin cytoskeleton (Treanor et al., 2010) and CD19
is kept relatively immobile by the CD81-tetraspanin network
(Mattila et al., 2013). Actin cytoskeleton disruption increases
BCR diffusion, leading to signal induction. This ligand-indepen-
dent signal not only requires an increased BCR diffusion but
also an immobilized co-receptor CD19. In the absence of
CD81, CD19 mobility on the B cell surface increases, failing to
promote BCR signaling induced by cytoskeleton disruption.
CD19 mobility increased even more by treating Cd81/ cells
with LatA (Mattila et al., 2013).We concluded that CD19 diffusion
correlates with CD81 expression and in the absence of CD81,
CD19 diffusion is partially controlled by the actin cytoskeleton.
We now propose that in the absence of WIP, altered dynamics
of the actin cytoskeleton together with a diminished expression
of CD81 induce a faster diffusion of CD19. This might cause a
dysregulated function of CD19 because both its diffusion and or-
ganization might be altered. In line with this suggestion, ligand-
independent actin cytoskeleton disruption induced a delayed
Ca2+ flux and almost absent signaling in B cells lacking WIP.
A growing body of evidence suggests a crucial role for
changes in actin dynamics in mediating signal integration from
a multitude of surface receptors. On the basis of our findings,
we propose that WIP, and possibly other actin regulators, are
essential to control correct organization of the actin cytoskeleton
and receptormobility. This might be especially critical in the case
of a low amount of signaling (e.g., monovalent antigen) or tonic
signaling requiring signal amplification via CD19. Altered recep-
tor dynamics, such as seen in the absence ofWIP, might hamper
receptor crosstalk and limit CD19 in its function as a general hub
for PI3K signaling, thereby influencing critical survival and differ-
entiation signals for mature B cells.
EXPERIMENTAL PROCEDURES
For an extended description of experimental procedures, see the Supple-
mental Information.
Mice
Wipf1/ mice (Anto´n et al., 2002) were a kind gift from Raif Geha (Boston’s
Children Hospital); Igh-Jtm1Dhu mice (BALB/c JHT; Chen et al., 1993) were
purchased from Taconic Bioscience; CBy.SJL(B6)-Ptprca/J mice (BALB/c
CD45.1) were purchased from The Jackson Laboratory. BALB/c WT and
C57BL/6 WT mice, CD19cre+/+ (referred to as Cd19/) (Rickert et al., 1995)
mice were obtained from the breeding facility at Cancer Research UK
(CRUK). Gene targeted mice were bred and maintained at the animal facility
of CRUK. Radiation chimeraswere generated using standard protocols.Mixed
chimeras were generated by injecting a mixture of 80% of Balb/c JHT with
20%WT orWipf1/BM into Balb/c JHT or Balb/c CD45.1mice or by injecting
a 1:1 mixture of Balb/c CD45.1WT and CD45.2Wipf1/ into CD45.1 mice. All
experiments were approved by the Animal Ethics Committee of Cancer
Research UK and the UK Home Office.
Immunization and Infection
For infection, mice were injected with a low dose (13 104 PFU) of Vaccinia vi-
rus WR strain (VV) intra footpad and mice sacrificed 8 days later. Draining
popliteal lymph nodes were analyzed by flow cytometry. For immunization,
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mice were injected i.p. with 50 mg NP33-KLH (Biosearch Technology) in 4 mg
Alum (ThermoScientific).
Immunoblotting
Splenic naive B were purified using negative B cell isolation kits yielding
enriched populations of about 95%–98% (Miltenyi). Purified splenic B cells
were stimulated with 3 mg/mL anti-k antibody (HB558, ATCC), 200 ng/ml
BAFF (Peprotech), 2.5 ng/ml CXCL12, 0.5 mg/mL CXCL13, 0.5 mg/mL CD40L
(all R&D systems), 5 mg/mL LPS, or 1 mM Latranculin A (Calbiochem). Lysates
were prepared using lysis buffer with 1% NP-40. Immunoblotting was per-
formed using standard procedures. Blot densitometry analysis was performed
using the ImageJ software.
Generation of Wipf1–/– Cell Lines
WIP was deleted in A20 cells and WEHI-231 cells using CRISPR/Cas9 sys-
tem (Cong et al., 2013; Ran et al., 2013). Briefly, custom-designed plasmids
expressing the gRNA and Cas9-GFP protein in a single vector (U6gRNA-
Cas9-2A-GFP) were bought from Sigma-Aldrich. The following target sites
within the coding region of WIP were used: CACTGGCGCCGGCTCCCT
TTGG and AGGGAGCCGGCGCCAGTGCTGG. The cell lines were transiently
transfected with the desired vector for 12 hr followed by single-cell sorting of
GFP-positive cells into a 96-well plate containing complete B cell medium.
After 2 weeks, the individual colonies were screened for WIP deletion by
immunoblotting.
Single Particle Tracking
Single particle tracking was performed and analyzed as previously described
(Mattila et al., 2013; Treanor et al., 2010). Briefly, primary naive B cells were
labeled with limiting dilutions of Atto633 or Atto488 conjugated anti-CD19
Fab (1D3), anti-IgD Fab (11-26c), or anti-IgM Fab (Jackson ImmunoResearch)
for 10 min on ice and washed with PBS. Cells were then resuspended in imag-
ing buffer and allowed to settle on anti-MHCII-coated coverslips in Focht
Chamber System 2 (FCS2) chambers (Bioptechs) at 37C for 2 min prior to im-
aging with TIRFM for 15 min. Single particle tracking data was analyzed and
confinement size was calculated as described (Mattila et al., 2013; Treanor
et al., 2010).
Experimental Data and Statistical Analysis
All statistical comparisons were carried out using the nonparametric two-tailed
Student’s t test and p values were calculated using PRISM software. Statisti-
cally significant differences are indicated on the figures as follows: *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and three movies and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.09.004.
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